Skip to main content
logo
Surgical Science Sweden AB (publ) (STO:SUS)
Sweden flag Sweden · Delayed Price · Currency is SEK
31.18
-1.12 (-3.47%)
At close: Mar 2, 2026

STO:SUS Revenue

In the year 2025, Surgical Science Sweden AB had annual revenue of 992.34M SEK with 12.25% growth. Surgical Science Sweden AB had revenue of 268.85M in the quarter ending December 31, 2025, with 6.88% growth.

Revenue
992.34M
Revenue Growth
+12.25%
P/S Ratio
1.60
Revenue / Employee
3.17M
Employees
313
Market Cap
1.59B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025992.34M108.26M12.25%
Dec 31, 2024884.09M1.23M0.14%
Dec 31, 2023882.85M80.31M10.01%
Dec 31, 2022802.54M435.76M118.81%
Dec 31, 2021366.78M261.98M249.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Getinge AB34.97B
Swedish Orphan Biovitrum AB28.24B
Medicover AB25.74B
Sectra AB3.47B
Stille AB567.63M
EQL Pharma AB425.75M
Carasent AB343.82M
Devyser Diagnostics AB250.50M
Revenue Rankings

Surgical Science Sweden AB News

More News